Current treatment for diabetes: a holistic approach
Abstract
In recent years, the global prevalence of diabetes has increased significantly, with type 2 diabetes (T2D) being recognized as a major public health concern. Its intricate and heterogeneous pathophysiology, the potential for serious complications, and the strong influence of lifestyle factors on glycemic control underscore the need for individualized treatment strategies. Effective management should integrate both tailored pharmacotherapy and lifestyle interventions, adapted to each patient’s unique needs. The aim of this narrative review is to explore the essential components of optimal diabetes care, emphasizing the importance of personalized approaches. We highlight findings from key cardiovascular outcome trials (CVOTs) to demonstrate the benefits of certain therapeutic agents that extend beyond glycemic control. Finally, drawing from our clinical experience, we propose practical strategies for the comprehensive, patient-centered management of diabetes.
Read the paper
Related studies
- The Role of AMPK Activation for Cardioprotection in Doxorubicin-Induced Cardiotoxicity
- Hypoglycemic medicines in the treatment of Alzheimer’s disease: Pathophysiological links between AD and glucose metabolism
- Isorhamnetin Reduces Glucose Level, Inflammation, and Oxidative Stress in High-Fat Diet/Streptozotocin Diabetic Mice Model
- Modulating Sirtuin Biology and Nicotinamide Adenine Diphosphate Metabolism in Cardiovascular Disease—From Bench to Bedside
- Characterization of the SGLT2 Interaction Network and Its Regulation by SGLT2 Inhibitors: A Bioinformatic Analysis
- Early Treatment with Empagliflozin and GABA Improves β-Cell Mass and Glucose Tolerance in Streptozotocin-Treated Mice
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.